Records containing: Scleroderma, Systemic
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2023-04-10Telerehabilitation Approach on Individuals With Hand-Affected Scleroderma
-
CLINICAL_TRIALS study record update · 2023-02-01A Partially Nested RCT to Evaluate the Effectiveness of the Scleroderma Patient-centered Intervention Network COVID-19 Home-isolation Activities Together (SPIN-CHAT) Program to Reduce Anxiety Among At-Risk Scleroderma Patients
-
CLINICAL_TRIALS study record update · 2022-11-17The Influence of Extracorporeal Photopheresis on Skin Sclerosis - an Exploratory Clinical Study
-
CLINICAL_TRIALS study record update · 2022-09-29Clinical Efficacy of Inhibition of Organ Dysfunction Through Bermekimab in Systemic Sclerosis: A Proof- Of-Concept Double-Blind Randomized Clinical Trial (the Light Trial)
-
CLINICAL_TRIALS study record update · 2022-05-20Measurement Properties and Performance of Functional Exercise Tests in Patients With Systemic Sclerosis
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2022-04-28Implementing a Novel Splinting Technique Using 3D Models for Patients With Scleroderma and Arthritis: A Pilot Study
-
CLINICAL_TRIALS study record update · 2022-04-13Investigation of the Effectiveness of Telerehabilitation on Individuals With Hand-Affected Scleroderma
-
CLINICAL_TRIALS study record update · 2021-09-20Oral Manifestations of Systemic Sclerosis: Toward the Identification of New Prognostic Markers
-
CLINICAL_TRIALS study record update · 2021-08-31The Scleroderma Patient-centered Intervention Network - Scleroderma Support Group Leader EDucation Program Trial (SPIN-SSLED)
-
CLINICAL_TRIALS study record update · 2021-05-24A Multi-center, Randomized, Double-blind (Sponsor Open), Placebo-controlled, Repeat-dose, Proof of Mechanism Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Explore Efficacy of GSK2330811 in Participants With Diffuse Cutaneous Systemic Sclerosis
-
CLINICAL_TRIALS study record update · 2021-04-21Immunomodulating Effects of Supplementation With 25 oh Vitamin D in Adults With Scleroderma and Hypovitaminosis D
-
CLINICAL_TRIALS study record update · 2021-02-10Autologous Fat Grafting in the Treatment of Critical Limb Ischaemia Non Suitable for Revascularization: The Adipose Tissue - Critical Limb Ischaemia (ADIPOCLI) Trial Protocol
-
CLINICAL_TRIALS study record update · 2020-11-09A Phase I Trial to Investigate the Effect of Nintedanib on the Pharmacokinetics of a Combination of Ethinylestradiol and Levonorgestrel in Female Patients With Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)
-
CLINICAL_TRIALS study record update · 2020-07-23Randomized Study of Different Non-myeloablative Conditioning Regimens With Hematopoietic Stem Cell Support in Patients With Scleroderma (Autologous Systemic Sclerosis Immune Suppression Trial - II ASSIST-IIb)
-
CLINICAL_TRIALS study record update · 2020-04-10Therapeutic Iontophoresis of Treprostinil in Systemic Sclerosis Digital UlcErations. A Proof of Concept Study
-
CLINICAL_TRIALS study record update · 2020-02-18Double-Blind, Parallel-group Comparison, Investigators Initiated Phase II Clinical Trial of IDEC-C2B8 (Rituximab) in Patients With Systemic Sclerosis
-
CLINICAL_TRIALS study record update · 2019-12-13A Double Blind, Randomised, Placebo-controlled Trial Evaluating Efficacy and Safety of Oral Nintedanib Treatment for at Least 52 Weeks in Patients With Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)
-
CLINICAL_TRIALS study record update · 2019-10-18A Phase 2, Proof-Of-Concept, Multicenter, Randomized, Double-Blind, Placebo- Controlled, Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of Pomalidomide (CC-4047) in Subjects With Systemic Sclerosis With Interstitial Lung Disease
-
CLINICAL_TRIALS study record update · 2019-03-13Reduce Disease Activity in Systemic Sclerosis by Transplantation of an Anaerobically Cultivated Human Intestinal Microbiota, a Controlled Interventional Pilot Trial
-
CLINICAL_TRIALS study record update · 2019-03-05Subcutaneous Injection of Autologous Adipose Tissue-derived Stromal Vascular Fraction Into the Fingers of Patients With Systemic Sclerosis : Controlled Clinical Trial With Efficacy Assessment
-
CLINICAL_TRIALS study record update · 2019-01-25A Randomized, Double-Blind, Placebo-Controlled Phase II Study to Investigate the Efficacy and Safety of Riociguat in Patients With Diffuse Cutaneous Systemic Sclerosis (dcSSc)
-
CLINICAL_TRIALS study record update · 2018-12-13The Clinical Efficacy And Subclinical Effects on Arterial STIFFNESS of Bosentan Therapy Added to Usual Care in Patients With Systemic Sclerosis With Digital Ulcers
-
CLINICAL_TRIALS study record update · 2018-12-06A Comparison Between Two Educational Methods in the Rehabilitation of the Microstomia in Systemic Sclerosis: a Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2018-09-07Obstructive Sleep Apnea in Scleroderma and Pulmonary Involvement
-
CLINICAL_TRIALS study record update · 2018-09-06Role of Circulating Cytotoxic Lymphocytes in Endothelial Cell Injury in Systemic Sclerosis